Trials / Recruiting
RecruitingNCT06305390
Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 167 (estimated)
- Sponsor
- IRCCS San Raffaele · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This project aims to evaluate the role of fully hybrid PET/MRI with 18FPSMA and multiparametric MR imaging (mpMRI) as one-stop approach for the diagnosis of clinically significant prostate cancer (csPCa). Our main hypothesis is that adding 18F-PSMA PET to mpMRI prior to biopsy, will reduce the number of false negative findings, while at the same time, allowing also to reduce the number of unnecessary prostate biopsies in patients with low-risk, clinically indolent PCa.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PET/MRI | 18F-PSMA PET/MRI |
Timeline
- Start date
- 2023-12-04
- Primary completion
- 2026-03-24
- Completion
- 2027-04-01
- First posted
- 2024-03-12
- Last updated
- 2026-04-01
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06305390. Inclusion in this directory is not an endorsement.